iRadimed Stock (NASDAQ: IRMD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 100.00 / 49.70K |
Day Range | - - - |
52 Wk Range | 36.12 - 50.85 |
Market Cap | $572.42M |
P/E Ratio | 32.29 |
Dividend Yield | 1.33% |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 1.8% |
Days to Cover | 2.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of iRadimed (NASDAQ:IRMD) through any online brokerage.
Other companies in iRadimed’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), SI-BONE (NASDAQ:SIBN), Semler Scientific (NASDAQ:SMLR) and Sight Sciences (NASDAQ:SGHT).
There is no analysis for iRadimed.
iRadimed has a consensus price target of $50.50.
The stock price for iRadimed (NASDAQ: IRMD) is $45.2 last updated July 19, 2024 at 4:01 PM EDT.
A quarterly cash dividend of 0.15 per share of Class A Common Stock. The quarterly cash dividend was payable on May 30, 2024 to stockholders of record on May 17, 2024.
iRadimed’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for iRadimed.
iRadimed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.